Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
ApartmentLove (C.APLV) Announces Agreement with Yardi (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Catalyst Biosciences Inc
CBIO
Healthcare
Biotechnology
Catalyst Biosciences, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of Hydronidone for the treatment of nonalcoholic steatohepatitis (NASH), a severe form of nonalcoholic fatty liver disease in the United States. Hydronidone is being evaluated for the treatment of liver fibrosis associated with a spectrum of chronic liver diseases. A Phase...
1 clinical trial of Hydronidone has been completed in the United States and generated pharmacokinetic (PK), safety and tolerability data of single and multiple ascending doses of Hydronidone in United States healthy subjects. Hydronidone is a structural analogue of the approved anti-fibrotic (pulmonary fibrosis) drug pirfenidone. Hydronidone has been shown to inhibit both p38y kinase activity and TGF-b1- induced excessive collagen synthesis in vitro in hepatic stellate cells (HSCs), which are recognized as critical events in the development and progression of fibrosis in the liver.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CBIO)
New Post
View:
Posts & Comments
Threaded Posts
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 24, 2022 11:34am
CBIO ....might be worth a stab sub $1.20
on this PB ....JMHO Cheers !
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 24, 2022 11:18am
CBIO .....sold on that rip !
Cheers !
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 24, 2022 11:17am
CBIO ...... Yeeha !!!!!!
Cheers !
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 24, 2022 11:03am
CBIO ..... Interesting Pivot happening now
Cheers !
(82)
•••
Iseneschal
X
Post by
Iseneschal
on May 24, 2022 9:53am
CBIO ....On watch....Yesterdays NR !
Catalyst Biosciences Sells Complement Portfolio for $60 Million 2022-05-23 05:30 ET - News Release SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Catalyst
...more
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 19, 2019 10:54am
it's a buy today for me
got it this morning for $5.95 per share,should do a nice rebound to the upside from here,so glta.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
NorthStar Gaming inks $10 million deal with Playtech to expand into the rest of Canada
Copper Exploration Company is on the Edge of a Big Discovery
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Advanced Project Opportunities Throughout Argentina’s Lithium Triangle
Private Placement: Ready for a Golden Opportunity in Ghana and Canada?
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
Total revenue Increased 47% with Two +28% Dividend Increases in 6 Months – Learn More Here
Discover Lithium Recycling at the Epicentre of the Largest EV Build Out in US History